172 related articles for article (PubMed ID: 10676150)
1. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
Nauwynck HJ; Labarque GG; Pensaert MB
Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
[TBL] [Abstract][Full Text] [Related]
2. Protection of fattening pigs against challenge with Aujeszky's disease virus after a successive intranasal/intramuscular vaccination.
Labarque GG; Nauwynck HJ; Maes DG; Pensaert MB
Vet Q; 1999 Jun; 21(3):104-7. PubMed ID: 10427636
[TBL] [Abstract][Full Text] [Related]
3. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
Van Oirschot JT
Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
De Leeuw PW; Van Oirschot JT
Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
van Oirschot JT
Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
Van Oirschot JT; De Leeuw PW
Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of maternally immune pigs with a live Aujeszky's disease vaccine by coarse spray and other routes.
Chong YC; Ng FK
Vet Microbiol; 1994 Mar; 39(1-2):117-24. PubMed ID: 8203117
[TBL] [Abstract][Full Text] [Related]
8. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
[TBL] [Abstract][Full Text] [Related]
9. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines.
Nauwynck HJ; Zonnekeyn V; Pensaert MB
Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303
[TBL] [Abstract][Full Text] [Related]
10. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
Arellano PE; Morrison RB; Molitor TW; Thawley DG
J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against Aujeszky's disease by different routes using live attenuated and inactivated virus vaccines in pigs with or without passive immunity.
Vannier P
Zentralbl Veterinarmed B; 1986 Nov; 33(9):704-12. PubMed ID: 3030027
[No Abstract] [Full Text] [Related]
12. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus.
McFerran JB; Dow C
Res Vet Sci; 1975 Jul; 19(1):17-22. PubMed ID: 168626
[TBL] [Abstract][Full Text] [Related]
13. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
Mikulska-Skupień E; Szweda W; Procajło Z
Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
[TBL] [Abstract][Full Text] [Related]
15. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection.
Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A
J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130
[TBL] [Abstract][Full Text] [Related]
16. Intranasal vaccination of pigs against Aujeszky's disease. 1. Comparison of intranasal and parenteral vaccination with an attenuated vaccine in 12-week-old pigs from immunized dams.
de Leeuw PW; Wijsmuller JM; Zantinga JW; Tielen MJ
Vet Q; 1982 Apr; 4(2):49-56. PubMed ID: 6287698
[No Abstract] [Full Text] [Related]
17. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.
Vannier P; Hutet E; Bourgueil E; Cariolet R
Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
Kimman TG
Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
[TBL] [Abstract][Full Text] [Related]
19. Influence of vaccine medium and vaccination schedules on the induction of active immunity against Aujeszky's disease in maternally immune pigs.
De Smet K; De Waele K; Pensaert M
Res Vet Sci; 1994 Jan; 56(1):89-94. PubMed ID: 8146460
[TBL] [Abstract][Full Text] [Related]
20. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
